ALX ONCOLOGY HOLDINGS INC (ALXO)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-391.4%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $0 | $1.18M | $4.80M | $2.07M | — |
| Operating Income | -$104.02M | -$142.47M | -$170.28M | -$127.44M | -$83.56M | -$43.66M | -$19.18M | -$13.68M | — |
| Net Income | -$101.69M | -$134.85M | -$160.81M | -$123.48M | -$83.46M | -$45.74M | -$19.24M | -$13.73M | — |
| EPS (Diluted) | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 | $-2.76 | — | — | — |
| Total Assets | $59.05M | $147.78M | $242.55M | $306.49M | $380.18M | $436.05M | $10.68M | — | — |
| Total Liabilities | $33.06M | $34.16M | $52.84M | $43.02M | $17.13M | $6.21M | $10.95M | — | — |
| Shareholders' Equity | $25.98M | $113.62M | $189.71M | $263.46M | $363.05M | $429.85M | -$70.64M | -$51.78M | -$38.41M |
| Cash & Equivalents | $16.37M | $17.57M | $22.41M | $48.82M | $363.67M | $434.22M | $9.02M | — | — |
| Operating Cash Flow | -$84.14M | -$121.91M | -$130.36M | -$89.22M | -$68.10M | -$38.29M | -$14.25M | -$13.19M | — |
| Capital Expenditures | $212.0K | $447.0K | $1.27M | $1.43M | $666.0K | $31.0K | $353.0K | $653.0K | — |
| Shares Outstanding | 54.39M | 53.05M | 49.95M | 40.86M | 40.59M | 39.84M | 3.17M | — | — |